Value of an active surveillance policy to document clearance of meticillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci amongst inpatients with prolonged admissions

Journal of Hospital Infection

Volumn 88, Issue 4, 2014, Pages 230-233

  Ghosh, A ^a   Jiao, L ^a   Al Mutawa, F ^a   O'Neill, C ^b   Mertz, D ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Carriage; Clearance; Contact precautions; Isolation; MRSA; Surveillance; VRE

Indexed keywords

ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; COST BENEFIT ANALYSIS; COST CONTROL; HEALTH CARE POLICY; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANTIBIOTIC RESISTANCE; CROSS INFECTION; ECONOMICS; EPIDEMIOLOGICAL MONITORING; HOSPITALIZATION; INFECTION CONTROL; ISOLATION AND PURIFICATION; LENGTH OF STAY; MICROBIOLOGY; PROCEDURES;

COST-BENEFIT ANALYSIS; CROSS INFECTION; EPIDEMIOLOGICAL MONITORING; HOSPITALIZATION; HUMANS; INFECTION CONTROL; INPATIENTS; LENGTH OF STAY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84920029271     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2014.09.011     Document Type: Article

References (10)

1. Siegel J.D., Rhinehart E., Jackson M., Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007, 35(Suppl. 2):S165-S193.
2. Morgan D.J., Diekema D.J., Sepkowitz K., Perencevich E.N. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 2009, 37:85-93.
3. Shenoy E.S., Walensky R.P., Lee H., Orcutt B., Hooper D.C. Resource burden associated with contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: the patient access managers' perspective. Infect Control Hosp Epidemiol 2012, 33:849-852.
4. Kluytmans J., van Belkum A., Vergrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Micriobiol Rev 1997, 10:505-520.
5. Robicsek A., Beaumont J.L., Peterson L.R. Duration of colonization with methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2009, 48:910-913.
6. Scanvic A., Denic L., Gaillon S., Giry P., Andremont A., Lucet J.C. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001, 32:1393-1398.
7. Sohn K.M., Peck K.R., Joo E.J., et al. Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital. Int J Infect Dis 2013, 17:e240-e246.
8. Shenoy E.S., Kim J., Rosenberg E.S., et al. Discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction. Clin Infect Dis 2013, 57:176-184.
9. Papia G., Louie M., Tralla A., Johnson C., Collins V., Simor A.E. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective?. Infect Control Hosp Epidemiol 1999, 20:473-477.
10. Mertz D., Frei R., Periat N., et al. Exclusive Staphylococcus aureus throat carriage: at-risk populations. Arch Intern Med 2009, 169:172-178.